๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity

โœ Scribed by Wilhelm H. Schmitt; Christoph Heesen; Elena Csernok; Annegret Rautmann; Wolfgang L. Gross


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
770 KB
Volume
35
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

โœฆ Synopsis


To investigate whether soluble interleukin-2 receptor (sIL-~R), a marker of T cell activation, could be a useful marker of disease activity in Wegener's granulomatosis (WG).

Methods. Soluble IL-2R levels were determined by enzyme-linked immunosorbent assay. WG disease activity in 102 patients was assessed according to clinical features and levels of classic antineutrophil cytoplasmic antibody (c-ANCA) and C-reactive protein (CRP).

Results. Soluble IL-2R levels were higher in patients with generalized and active disease than in those with limited and inactive disease. In 25 patients with complete clinical remission, sIL-2R levels were significantly elevated, although levels of CRP and c-ANCA were normal. Eight of these 25 patients had disease relapses within 6 months. Levels of sIL-2R were significantly higher in patients who had relapses than in those who did not. Patients with clinically active WG but low c-ANCA or CRP levels had elevated levels of Conclusion. Levels of sIL-2R correlate with disease activity in patients with WG, and may indicate imminent relapse.


๐Ÿ“œ SIMILAR VOLUMES


Soluble interleukin-2 receptor: Elevated
โœ A. B. Carpenter; C. H. Eisenbeis; Jr.; S. Carrabis; M. C. Brown; S. H. Ip ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 452 KB

Soluble interleukin-2 receptor (sll-2R) levels were quantitated in the seum and synovial fluid (SF) of patients with rheumatoid arthritis (RA) and degenerative joint disease (DJD). A sandwich immunoassay, employing two monoclonal antiodies against distinct epitopes on the lL-2R, was utilized for mea

Serum soluble TNF receptor I and II leve
โœ Tanja Spoettl; Martin Hausmann; Frank Klebl; Andrea Dirmeier; Bodo Klump; Joerg ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 170 KB

Background: Tumor necrosis factor alpha (TNFโฃ) is a proinflammatory cytokine and an important mediator in the pathophysiology of inflammatory bowel disease (IBD). The effects of TNFโฃ are mediated by 2 specific receptors, a 55-kDa protein (TNF-RI) and a 75-kDa receptor (TNF-RII), which are usually bo

Elevated soluble interleukin-2 receptor
โœ E. C. Keystone; K. M. Snow; C. Bombardier; Chi-Hsing Chang; D. L. Nelson; L. A. ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 611 KB

In a previous study, we used an enzyme-linked immunosorbent assay to measure soluble human interleukin-2 receptors (IL3R), and found that when activated lymphocytes produce cell-associated IL-2R, they also release a soluble form of IL3R into culture supernatants in vitro. Soluble IL-2R have also bee